Search | IOVS | ARVO Journals

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Lipophenols as new therapeutics toward retinal degeneration: in vitro and in vivo pharmacological studies

Esperance Moine; Nicolas Taveau; Maxime Vincent; Laurent Guillou; Sylvie Begu; Joseph Vercauteren; Thierry Durand; Celine Crauste; Philippe Brabet

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4939. doi:

ARVO Annual Meeting Abstract June 2017

A phloroglucinol-DHA derivative protects against light-induced retinal degeneration in an Abca4-deficient mouse model

Philippe Brabet; Aurélie CUBIZOLLE; Céline CRAUSTE; Laurent GUILLOU; Anne-Laure BONNEFONT; Joseph VERCAUTEREN; Thierry DURAND; Christian P Hamel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2031. doi:

ARVO Annual Meeting Abstract June 2017

A human iPSc-derived RPE model of Retinitis Punctata Albescens

Krishna Damodar; Nejla Erkilic; Laurent GUILLOU; Daria Mamaeva; Marie Pequignot; Aude Conscience; Lorenne Robert; Philippe Brabet; Christian P Hamel; Vasiliki Kalatzis

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):625. doi:

ARVO Annual Meeting Abstract June 2015

Human FATP1 overexpression in mouse retinal pigment epithelium.

Aurélie Cubizolle; laurent guillou; Claire Angebault; marie seveno; chantal cazevieille; Guy Lenaers; Philippe Brabet; Christian P Hamel

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5456. doi:

ARVO Annual Meeting Abstract June 2015

Polyunsaturated Fatty Acid-Phloroglucinol conjugates protect RPE and Neural Retina against All- trans -Retinal-induced Damages

Philippe Brabet; Cubizolle Aurélie; David Cia; Celine Crauste; laurent guillou; Nathalie Jacquemot; Claire Vigor; Claire Angebault; Joseph Vercauteren; Christian P Hamel

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):29. doi:

ARVO Annual Meeting Abstract June 2013

Assessment of the therapeutic value of phloroglucinol in Stargardt’s disease

Philippe Brabet; David Cia; Claire Vigor; Nathalie Jacquemot; Benoit Lerat; Laurent Guillou; Celine Crauste; Christian Hamel; Joseph Vercauteren

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1949. doi:

ARVO Annual Meeting Abstract March 2012

Slowing Down The Visual Cycle By The Fatp1 Protein

Philippe Brabet; Laurent Guillou; Karim Chekroud

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3356. doi:

ARVO Annual Meeting Abstract April 2010

Exploration of the Visual Cycle in Fatp1-Deficient Mice

K. Chekroud; M. O. Pequignot; L. Guillou; E. Brun; C. P. Hamel; P. Brabet

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1301. doi:

ARVO Annual Meeting Abstract April 2009

Glycolytic Enzyme Modulates the Cellular Distribution and Isomerase Activity of Rpe65

P. Brabet; K. Chekroud; L. Guillou; J. Andries; M. O. Péquignot; C. P. Hamel

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3400. doi:

ARVO Annual Meeting Abstract May 2008

Reconstitution of the Human Visual Cycle Multiprotein Network in Insect Cells

P. Brabet; L. Guillou; T. J. Guignard; M. O. Péquignot; K. Chekroud; C. Joly; Y. Boublik; C. P. Hamel

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3517. doi:

ARVO Annual Meeting Abstract May 2008

Towards a Role of FATP1 in the Retinal Pigment Epithelium Visual Cycle

O. Payet; M. O. Pequignot; T. J. Guignard; L. Guillou; K. Chekroud; C. P. Hamel; P. Brabet

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3525. doi:

Advertisement